| Dr Anthony Joseph Zapanta, DDS | |
|
1170 Live Oak Blvd, Yuba City, CA 95991-3407 | |
| (530) 671-9555 | |
| Not Available |
| Full Name | Dr Anthony Joseph Zapanta |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 1170 Live Oak Blvd, Yuba City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164208187 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 109119 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony Joseph Zapanta, DDS 2219 Montevoit Ct, San Jose, CA 95138-2256 Ph: (408) 887-5907 | Dr Anthony Joseph Zapanta, DDS 1170 Live Oak Blvd, Yuba City, CA 95991-3407 Ph: (530) 671-9555 |
News Archive
A class of compounds that interferes with cell signaling pathways may provide a new approach to cancer treatment, according to a study published online this week in the Proceedings of the National Academy of Sciences (PNAS) Early Edition. The compounds, called PITs (non-phosphoinositide PIP3 inhibitors), limited tumor growth in mice by inducing cell death.
A continuing challenge that oncology nurses face is providing clear documentation of patient care. In order to maximize their ability to improve patient outcomes, nurses at The Cancer Institute of New Jersey (CINJ) have developed an electronic documentation tool that integrates a number of key measurement and evaluation resources utilized in the oncology nursing field.
Patients are emerging as an increasingly strong group when it comes to influencing the success and failure of new drugs - according to a newly published New Health Report commissioned by Quintiles to gauge the opinions of biopharma executives, managed care executives and patients, and to track progress in the New Health.
The Lancet has published details of a new point-of-care test for Ebola virus that is as sensitive as the conventional laboratory test, but provides results within minutes.
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera Pharmaceuticals (Switzerland) Ltd., a subsidiary of Santhera Pharmaceuticals Holding AG (SIX: SANN) to acquire the U.S. and Canadian rights to develop and commercialize Santhera's JP-1730/fipamezole for the treatment of Dyskinesia in Parkinson's Disease (DPD). JP-1730/ fipamezole is a first-in-class compound that, in a recent Phase IIb study, displayed the potential to reduce levodopa-induced dyskinesia.
› Verified 1 days ago
Navneet Shergill, Dentist Medicare: Not Enrolled in Medicare Practice Location: 415 Alturas St, Yuba City, CA 95991 Phone: 916-722-4900 | |
Dr. Patricia Bezad, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 1054 Harter Rd., #5, Yuba City, CA 95993 Phone: 916-749-0990 Fax: 530-755-9887 | |
Flordeliza D Flores, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1408 Live Oak Blvd, Suite C, Yuba City, CA 95991 Phone: 530-742-0388 Fax: 530-742-0736 | |
Dr. Petr Kadera, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 871 Gray Ave, Suite B, Yuba City, CA 95991 Phone: 530-763-3222 Fax: 844-534-8464 | |
Jaspreet Singh Dhami, Dentist Medicare: Medicare Enrolled Practice Location: 727 Colusa Ave, Yuba City, CA 95991 Phone: 530-216-5022 | |
Dr. Sukhpreet Kaur Heer, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1892 Marjorie Dr, Yuba City, CA 95993 Phone: 530-300-2671 | |
Dr. Paramjit Singh Everest, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1045 Live Oak Blvd, Suite #a, Yuba City, CA 95991 Phone: 530-673-6565 |